Most Popular Stories
- Humana slammed after posting 65 percent increase in third quarter profits
- Medical liability premiums dropping nationwide
- Have health reform plans ignored wellness?
- Case study: NYC works to manage diabetes
- MRSA invading hospitals through outpatient traffic
- Alabama MDs say state Blue plan hasn't followed class-action agreement
Featured Jobs
-
Dir. of Med/Surgical Services Job in WA
StaffPointe, LLC - west central, WA -
Psych Nurse Practitioner Job in Michigan
StaffPointe, LLC - northeast, MI -
eClinicalWorks Project Manager
Indiana Health Centers, Inc. - Indianapolis, IN -
Pediatrician Job in Alabama JK740N
StaffPointe, LLC - Montgomery, AL -
Family Practitioner Job in Louisiana
StaffPointe, LLC - north, LA
Events
- Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - Harvard Business School 7th Healthcare Conference
January 30, 2010
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
Trend: States try to counter pharma drug marketing
As we reported last year, a small but growing number of advocates have begun working to provide their own brand of drug education to doctors--without the sales message that pharmaceutical companies deliver. These "counter-detailers," as they are known in some quarters, are paid by groups outside the industry to visit with doctors and provide neutral, hype-free information on medications. Previously, we told you about one effort, paid for by the state of Pennsylvania, which sent out 500 clinicians to discuss prescribing options.
Over the past year, it appears that the idea has become more popular. Today, a handful of states, including Pennsylvania, Vermont and South Carolina, have rolled out programs presenting drug cost and effectiveness information. Vermont's program focuses on rural medical practices, and South Carolina's focuses on mental-health drugs. Pennsylvania, which spends $1 million a year on its "unsales" force, has reported that it managed to cut costs on drugs for seniors with the program; for example, the state began saving $60 on average per doctor on pain relievers within six months after an unsales visit. However, it's not clear the others are successful. (Small wonder, given that the pharmaceutical industry spends more than $7 billion a year on direct marketing to doctors.)
To learn more about this trend:
- read this Associated Press piece
Related Articles:
MD discusses decision to ban pharma reps. Report
IFPMA institutes new pharma marketing rules. Report
"Counter-detailers" offer drug info alternative. Report
Related Stories
- Senators plan bill countering pharma detailing tactics
- Study: Antipsychotics don't manage aggressive outbursts
- Avandia gets black-box warning
- Amgen spending millions to fight CMS anemia drug limits
- Study: Some physicians uninformed about approved uses of drugs
- CT sues McKesson for allegedly inflating drug prices
- CA bill would let pharmacies sell patient prescription data
- Studies show problems with four big-name drugs
- ALSO NOTED: WellPoint exposes patient data; ED visits go up when OR trims Medicaid rolls; and much more...
- FTC: Pharmas cut 14 deals to delay generic sales in '07
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





